A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
The case of a 66-year-old man with severe chronic obstructive pulmonary disease (COPD) is presented. Diagnosis was based on baseline pulmonary function tests (PFTs) and clinical examination. Therapy with tiotropium 18 μg (once daily) and salmeterol/fluticasone 50/500 μg (twice daily) failed to achieve optimal disease control. Roflumilast (Daxas) 500 μg once daily was therefore added and a progressive improvement in the patient's condition was observed during the 1-year followup. In this patientdoi:10.4081/monaldi.2013.28 fatcat:un6f3p6xbjabfcuk7xdvqhs2lq